trans-Pralsetinib (Synonyms: trans-BLU-667) |
| Catalog No.GC61346 |
트랜스-프랄세티닙(trans-BLU-667)은 특허 US20170121312A1, 화합물 실시예 129에서 추출된 형질전환 중 재배열(RET) 억제제입니다.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2097132-93-7
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
trans-Pralsetinib (trans-BLU-667) is a rearranged during transfection (RET) inhibitor extracted from patent US20170121312A1, Compound Example 129[1].
[1]. Jason D. Brubaker, et al. Inhibitors of ret. US20170121312A1.
Review for trans-Pralsetinib
Average Rating: 5 (Based on Reviews and 27 reference(s) in Google Scholar.)
Review for trans-Pralsetinib
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *